Corporates: Novogen, CBH, Mirvac
Shares in biotechnology company, Novogen, more than halved yesterday after the company unveiled disappointing phase II trial results for the ovarian cancer trial of its drug, phenoxodiol. The shares closed down 53.1% at 18.5c, a loss of 21c on the day.
Read More